# A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors

> **NCT02366312** · PHASE2 · COMPLETED · sponsor: **NYU College of Dentistry** · enrollment: 2 (actual)

## Conditions studied

- Keratocystic Odontogenic Tumor

## Interventions

- **DRUG:** vismodegib

## Key facts

- **NCT ID:** NCT02366312
- **Lead sponsor:** NYU College of Dentistry
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-27
- **Primary completion:** 2019-08
- **Final completion:** 2019-08
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2021-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02366312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02366312, "A Phase 2, Single-center, Single-arm, Open Label Trial of Vismodegib in Patients With Keratocystic Odontogenic Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02366312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*